united healthcare glp-1 coverage weight loss Chart: 1 in 8 Americans Now Use Drugs for GLP-1 Medications for Weight Loss:
Description
95% CI: 0.037 to 0.013
The subsequent SURMOUNT-2 trial confirmed that those with diabetes also had significant weight loss
, Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults, Nature Reviews
Following the treatment is very important for effective long-term weight management
Further, the CVOTs in general also suggested a potential benefit of GLP-1 RAs on HF, positioning GLP-1 RAs as another advanced option alongside SGLT2 inhibitors in the otherwise sparse treatment armamentarium for especially HFpEF
